0%

Archive for August, 2017

Home2017 August

 From the Leukemia & Lymphoma Society FDA Approval: LLS Applauds New Advance for Acute Lymphoblastic Leukemia RYE BROOK, N.Y. (August 17, 2017) – The Leukemia & Lymphoma Society (LLS) applauds today’s approval by the U.S. Food and Drug Administration (FDA) of inotuzumab ozogamicin (Besponsa®) for the treatment of adults with relapsed or refractory B-cell precursor […]

color
https://nylencancercenter.com/wp-content/themes/yunik-installable/
https://nylencancercenter.com/
#39489C
style3
paged
Loading posts...
#39489C
on
none
loading
#39489C
Sort Gallery
https://nylencancercenter.com/wp-content/themes/yunik-installable
on
yes
yes
off
on
off
off